Tradestie Institutional Equity Comparison Engine

ENTX vs ICCC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ICCC Overall Edge

ICCC Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immucell Corp (ICCC) driven by superior Valuation, Growth & Margin, Momentum & Technical while ENTX counters with relative strength in Options & Structure. Fundamentally, ENTX trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus ICCC at N/M Forward P/E and 15.2% operating margin (+11.5% YoY). In options structure, ENTX sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro) against ICCC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ICCC
ENTX N/M vs ICCC N/M Fwd P/E
Growth & Margin Winner ICCC
Op Margin 0.0% vs 15.2% ยท YoY -100.0% vs +11.5%
Momentum & Technical Winner ICCC
1Y +10.2% vs +88.8% ยท 52W Pos 64% vs 91%
Options & Structure Winner ENTX
CONSOLIDATION (32nd %ile IV) vs UNCLASSIFIED (N/A IV)
ENTX NASDAQ
Entera Bio Ltd. Ordinary Shares
Biological Products, (No Disgnostic Substances)
$3.02
-2.89% 1D
Market Cap $541.6M
1M Return +12.69%
1Y Return +10.22%
Forward P/E N/M
Unified AI Score
53.9 / 100 HOLD
Tech 37.0 Fund 54.0 Flow 72.0 Mom 60.0
ICCC NASDAQ
Immucell Corp
In Vitro & In Vivo Diagnostic Substances
$11.42
+6.23% 1D
Market Cap $97.7M
1M Return +6.23%
1Y Return +88.76%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 48.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENTX +10.22% ICCC +88.76% Spread: +78.54 pp (ICCC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENTX Revenue ICCC Revenue ENTX Op. Margin ICCC Op. Margin Margin Edge
FY2018 N/A $10M N/A -13.2% ICCC
FY2019 N/A $10M N/A -7.0% ICCC
FY2020 $0M $20M -3059.7% -9.0% ICCC
FY2021 $0M $20M -2139.6% 1.3% ICCC
FY2022 $0M $20M -9714.2% -12.4% ICCC
FY2023 N/A $20M N/A -32.9% ICCC
FY2024 $0M $30M -5295.6% -6.2% ICCC
FY2025 $0M $30M -27450.0% 6.0% ICCC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENTX (3) vs ICCC (6)
Institutional Metric ENTX ICCC Criterion Row Winner
Market Capitalization Scale $541.6M $97.7M Larger Scale ENTX
Trailing P/E Ratio Valuation N/M 56.6x Lower Multiple ICCC
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% +11.5% Higher Growth ICCC
Operating Margin (TTM) Profitability 0.0% 15.2% Higher Margin ICCC
Net Profit Margin Profitability 0.0% 2.6% Higher Margin ICCC
Return on Equity (ROE) Capital Efficiency -20.3% 2.6% Higher ROE ICCC
52-Week Range Position Momentum 64% ($1โ€“$4) 91% ($5โ€“$12) Stronger Trend ICCC
Beta / 30D Volatility Risk Regime 1.07ฮฒ ยท 46% Vol 0.24ฮฒ ยท 46% Vol Lower Realized Risk ENTX
Unified Institutional Score Composite Signal 53.9 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite ENTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENTX vs ICCC Buy Guide
ENTX CONSOLIDATION
79d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ICCC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ICCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENTX nor ICCC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.